CompletedPhase 1Phase 2

Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF)

NCT00095706

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Central Hematology Oncology Medical Group, Inc.

Alhambra, California, United States

+17 additional locations

Save this trial

Central Hematology Oncology Medical Group, Inc.Alhambra, California, United States
Comprehensive Blood and Cancer CenterBakersfield, California, United States
Virginia K. Crosson Cancer CenterFullerton, California, United States
Pacific Shores Medical GroupLong Beach, California, United States
UCLA Medical CenterLos Angeles, California, United States
North Valley Hematology/Oncology Medical GroupNorthridge, California, United States
Ventura County Hematology-Oncology SpecialistsOxnard, California, United States
Wilshire Oncology Medical Group, Inc.Pomona, California, United States
Cancer Care Associates Medical Group, Inc.Redondo Beach, California, United States
Sansum Santa Barbara Medical Foundation ClinicSanta Barbara, California, United States
Santa Barbara Hematology Oncology Medical Group, Inc.Santa Barbara, California, United States
San Diego Cancer CenterVista, California, United States
Cancer Institute of Florida, P.A.Orlando, Florida, United States
Northeast Georgia Cancer Care, LLCAthens, Georgia, United States
Suburban Hematology-Oncology Associates, P.A.Lawrenceville, Georgia, United States
Northwest Georgia Oncology Centers, P.C.Marietta, Georgia, United States
Oncology Hematology Associates of Central Illinois, P.C.Peoria, Illinois, United States
Comprehensive Cancer Centers of NevadaLas Vegas, Nevada, United States